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NLRP3 is a key component of the macromolecular
signaling complex called the inflammasome that pro-
motes caspase 1-dependent production of IL-1b.
The adaptor ASC is necessary for NLRP3-dependent
inflammasome function, but it is not known whether
ASC is a sufficient partner and whether inflamma-
some formation occurs in the cytosol or in associa-
tion with mitochondria is controversial. Here, we
show that the mitochondria-associated adaptor
molecule, MAVS, is required for optimal NLRP3 in-
flammasome activity. MAVS mediates recruitment
of NLRP3 to mitochondria, promoting production of
IL-1b and the pathophysiologic activity of the
NLRP3 inflammasome in vivo. Our data support a
more complex model of NLRP3 inflammasome acti-
vation than previously appreciated, with at least
two adapters required formaximal function. Because
MAVS is a mitochondria-associated molecule previ-
ously considered to be uniquely involved in type 1
interferon production, these findings also reveal un-
expected polygamous involvement of PYD/CARD-
domain-containing adapters in innate immune
signaling events.INTRODUCTION
The vertebrate immune system uses a variety of sensors to
detect pathogens or tissue damage and mount an inflammatory
response for host defense or wound healing. Nod-like receptors
(NLRs) are a family of cytosolic proteins containing several
prototypic domains, including C-terminal leucine-rich repeats
(LRRs), a central nucleotide binding or oligomerization domain
(NBD, NOD, or NACHT), and N-terminal pyrin domain (PYD)
that detect ligands of microbial or endogenous origin and stimu-
late innate immune activities (Davis et al., 2011). Among NLRs,348 Cell 153, 348–361, April 11, 2013 ª2013 Elsevier Inc.NLRP3 is perhaps the best studied. NLRP3 forms a macromo-
lecular signaling complex called the inflammasome upon activa-
tion by a variety of signals, including infection and metabolic
dysregulation, but how these chemically and structurally diverse
entities elicit a response from a single sensor molecule is unclear
(Gross et al., 2011). One proposed common feature of NLRP3
activators is induction of reactive oxygen species (ROS) (Cruz
et al., 2007). The induced ROS is presumed to lead to the gener-
ation of a potential ligand of NLRP3 or to modify NLRP3 or asso-
ciated proteins directly (Zhou et al., 2010). Another reported
pathway involves disruption of lysosomes by crystals such as
those formed by uric acid or cholesterol, causing release of
active cathepsin B that presumably acts as an upstream acti-
vator of NLRP3 (Hornung et al., 2008).
Upon activation, NLRP3 oligomerizes with the adaptor protein
ASC and procaspase-1 (Agostini et al., 2004). This results in
autocatalytic cleavage and activation of caspase-1, which in
turn processes proforms of IL-1b or IL-18 to produce active cyto-
kine (Cerretti et al., 1992). NLRP3 and ASC are cytosolic pro-
teins, and the assembly of the inflammasome is believed to
occur in that cellular compartment. However, organellar recruit-
ment is well recognized for plasma membrane-associated or
endosomal TLRs (Blasius and Beutler, 2010) and for the RIG-
like helicases (RIG-I and MDA-5) that engage the mitochondrial
outer membrane protein MAVS (mitochondrial antiviral signaling
protein) in pathways leading to the production of type 1 inter-
feron (IFN) (Kawai et al., 2005; Meylan et al., 2005; Seth et al.,
2005). A recent report suggests a possible role for mitochondrial
recruitment of NLRP3 in inflammasome function (Zhou et al.,
2011), but this remains controversial. Some studies implicate
mitochondria as the cellular source of ROS and oxidized DNA
required for NLRP3 activation (Nakahira et al., 2011; Shimada
et al., 2012; Zhou et al., 2011); others indicate that ROS produc-
tion is required for priming and transcriptional induction of
NLRP3 expression, but not for NLRP3 activation (Bauernfeind
et al., 2011). If interaction with mitochondria is important for
NLRP3 function, how recruitment from the cytosol would be
mediated is unclear. CARD- and PYD-containing proteins can
interact with other proteins though homotypic or heterotypic
domain-domain interactions (Wagner et al., 2009), but apart
from ASC, an adaptor known to be crucial for NLRP3 function,
data on novel interacting partners in NLRP3 inflammasome
assembly or function are just emerging. One additional compo-
nent participating in NLRP3 inflammasome activity is guanylate
binding protein 5 (GBP5) (Shenoy et al., 2012), but there is no
evidence this new participant plays any role in connecting the
inflammasome to mitochondria.
Although these aspects of the basic biology of the NLRP3 in-
flammasome remain unresolved, there is little doubt about the
role of this signaling system in human disease. Gain of function
mutations in NLRP3 are responsible for severe human autoin-
flammatory syndromes, and neutralization of the excess active
IL-1b rapidly ameliorates symptoms and the pathological effects
of the overactive inflammatory process (Goldbach-Mansky and
Kastner, 2009). In addition, the NLRP3 inflammasome has
been implicated in the inflammatory response to dying cells in
the absence of infection (Rock et al., 2010). Such responses
are believed to contribute to tissue damage and disease severity,
for example, in acute kidney injury (Berry and Clatworthy, 2012).
To clarify the mechanistic aspects of NLRP3 activation,
including possible organellar recruitment, we conducted an
informatics-based structure-function analysis, which suggested
possible mitochondrial localization. Here, we demonstrate that
NLRP3 associates with mitochondria following activation, which
promotes optimal activity of the NLRP3 inflammasome in gener-
ating bioactive IL-1b in response to noncrystalline activators.
Surprisingly, this recruitment and effect on cytokine generation
required the mitochondria-associated adaptor protein MAVS,
whose interaction with NLRP3 depended on an N-terminal
sequence in the latter molecule. MAVS deficiency, like ASC defi-
ciency, protected mice from inflammasome-dependent renal
dysfunction and neutrophil influx in vivo during sterile inflamma-
tion in acute tubular necrosis. Our data thus provide a more
comprehensive model of NLRP3 inflammasome activation with
two adapters, MAVS and ASC, involved in optimal function
through a putatively sequential amplification process involving
mitochondrial membrane recruitment and then effector function.
They also reveal an unexpected role for MAVS as a mediator of
inflammasome activation beyond its well-defined role in antiviral
immunity and further support a role for mitochondria as plat-
forms integrating multiple innate signaling pathways.
RESULTS
Mitochondrial Localization of NLRP3 and ASC
Bioinformatic analysis of localization of NLRP3 using PSORT
(Gavel and von Heijne, 1990; Nakai and Kanehisa, 1992)
assigned the highest certainty score to mitochondria (Table
S1). To investigate if NLRP3 has a propensity to localize to mito-
chondria, we expressed NLRP3 in HEK293T cells by transient
transfection and visualized NLRP3 and mitochondria. NLRP3
almost completely colocalized with mitochondria under these
conditions in which NLRP3 is expressed at supraphysiologic
levels in the absence of known activating stimuli (Figures S1A
and S1B available online). In contrast, NLRP2 and NLRP4 did
not show such colocalization, indicating that mitochondrial
localization was not a general feature of NLR overexpression
(Figures S1A and S1B).HEK293T cells lack the adaptor ASC (Figure S1C), indicating
that NLRP3 association with mitochondria does not require
ASC. However, because ASC has an indispensible role in
NLRP3 inflammasome activity (Agostini et al., 2004), we exam-
ined whether ASC influences NLRP3 mitochondrial localization.
NLRP3 was overexpressed in HEK293T cells stably expressing
cytosolic ASC as a YFP fusion protein (HEK293-ASC-YFP cells)
(Hornung et al., 2009). Overexpression of NLRP3 in these cells
led to formation of large cytosolic aggregates (‘‘speckles’’),
which include ASC-YFP. NLRP3 localized to mitochondria (Fig-
ures S1D and S1E) and ASC formed a speckle that colocalized
with NLRP3 and mitochondria (Figures S1D, S1F, S1G and
S1I). Such mitochondrial association and speckle formation
was not observed for cells overexpressing NLRP4 or NOD1 (Fig-
ures S1D–S1I).
We were concerned that this localization of NLRP3 might not
reflect the behavior of the molecule in cells with more physiolog-
ical expression following addition of activating ligands and there-
fore established a stable expression system in which NLRP3
mRNA was transcribed in pyroptosis-resistant HEK293T cells
under the control of an inducible tetracycline promoter (Shin
et al., 2006). HEK293T cells lack P2X receptors and have low
phagocytic ability (Gu et al., 2010), making them relatively resis-
tant to some NLRP3-activating stimuli like ATP and crystalline
substances such as MSU and alum. Therefore, nigericin, an
ionophore that catalyzes an electroneutral potassium/proton ex-
change across lipid bilayers to induce NLRP3 activation, was
used as the stimulus.
Expression of NLRP3 was induced in stable transfectants by
doxycycline (DOX) and the cells analyzed by confocal micro-
scopy. When expressed at more physiological levels, NLRP3
was cytosolic in the resting state but localized to mitochondria
upon activation with nigericin (Figures 1A and 1B). Similar results
were obtained under transient expression conditions in cells
showing very low, and therefore closer to physiological, expres-
sion levels (Figures 1C and 1D). The fraction of NLRP3 that trans-
located to mitochondria upon nigericin stimulation was about
three- to five-fold lower than that observed under overexpres-
sion conditions (Figures S1B, S1E, 1B and 1D). These results
indicate that the mitochondrial localization of NLRP3 observed
under overexpression conditions in Figure S1 reflected an
activated phenotype, where forced self-association and/or
oligomerization of NLRP3 by expression at supraphysiological
levels in HEK293T cells was sufficient to drive NLRP3 to the
mitochondria. Consistent with these imaging data, subcellular
fractionation studies of wild-type (WT) bone-marrow-derived
macrophages (BMDMs) showed that NLRP3 was predominantly
cytosolic in untreated, resting BMDMs and localized to the mito-
chondrial fraction upon activation with nigericin (Figure 1E).
Similar results were obtained in ASC KO BMDMs, confirming
the ASC-independent nature of activation-induced NLRP3 mito-
chondrial localization (Figure 1E).
Mapping of the Mitochondrial Association Sequence of
NLRP3
To determine whether the PSORT-predicted N-terminal
mitochondrial presequence in NLRP3 was involved in recruit-
ment of activated NLRP3 to mitochondria, we conducted aCell 153, 348–361, April 11, 2013 ª2013 Elsevier Inc. 349
Figure 1. NLRP3 Is Cytosolic in the Resting State and Localizes to Mitochondria upon Activation
(A and B) Representative confocal immunofluorescence images (A) and quantification (B) of NLRP3 colocalized with Mitotracker in HEK293T cells stably ex-
pressing NLRP3. Expression of NLRP3 was induced with doxycycline (DOX; 1 mg/ml), and cells were either untreated or treated with 15 mM nigericin for 45 min
prior to imaging.
(C and D) Representative immunofluorescence images (C) and quantification (D) of NLR colocalized with Mitotracker in HEK293T cells expressing NLRP3 or
NLRP4 under transient low-expression conditions. Cells were transfected with 100 ng plasmid DNA for 8 hr, and were either untreated or treated with 15 mM
nigericin for 45 min prior to imaging.
(E) Subcellular fractionation ofWT and ASCKOBMDMs. BMDMswere either untreated (Mock) or primedwith LPS (1 mg/ml for 4 hr) prior to stimulationwith 7.5 mM
nigericin for 30 min (Nig). Mitochondrial (M) and cytosolic (C) fractions were fractionated and analyzed for expression of NLRP3 by immunoblot. Purity of the
fractions was assessed by blotting for Complex 1 (mitochondrial protein) and ERK-2 (cytosolic protein).
Imaging data are representative of several images from three independent experiments. Data points on graphs represent independent fields (with three to five
cells per field). Error bars are mean ± SEM, and p values from an unpaired t test (two-tailed) are shown. Mito, Mitotracker; coloc, colocalization channel. See also
Figure S1 and Table S1.mutagenesis study. When expressed in HEK293-ASC-YFP cells
under transient low-expression conditions, a deletion mutant of
NLRP3 that lacked 20 amino acids at the N terminus (NLRP3 D
2-21) (Figure 2A) exhibited complete loss of mitochondrial local-350 Cell 153, 348–361, April 11, 2013 ª2013 Elsevier Inc.ization and ASC speckle formation under both unstimulated (Fig-
ure S2,WT andD 2-21 panels) and nigericin-activated conditions
(Figure 2B, WT and D 2-21 panels). To more precisely map the
relevant sequence, we generated a series of N-terminal deletion
AB
Figure 2. NLRP3 Possesses an N-Terminal Sequence that Controls Mitochondrial Association and ASC Speckle Formation
(A) Panel of N-terminal deletions of NLRP3. ‘‘——’’ indicates the deleted sequence. Structured region of the NLRP3 PYD encompasses residues 6–90.
(B) Representative immunofluorescence images of HEK293-ASC-YFP cells expressing WT and N-terminal deletions of NLRP3 under transient low-expression
conditions (100 ng plasmid DNA for 8 hr), and activated with 15 mMnigericin for 45min prior to imaging. Representative images of unstimulated cells are shown in
Figure S2.
Imaging data are representative of several images from four independent experiments. Mito, Mitotracker. See also Figure S2.mutants of NLRP3 (D 2-3,D 2-5,D 2-7,D 2-9,D 2-11, andD 2-21;
Figure 2A), and examined their behavior using a transient, low-
expression system in HEK293-ASC-YFP cells. The deletion
mutants retained their ability to self-associate and were ex-
pressed at levels similar to the WT NLRP3 (Figures S3A and
S3B). Importantly, the D 2-3, D 2-5, D 2-7, and D 2-9 deletionsof NLRP3 preserved all the residues implicated in stability of
the pyrin domain in the NLRP3 PYD crystal structure (Bae and
Park, 2011).
Under unstimulated conditions, WT NLRP3 and its N-terminal
deletions were primarily localized to the cytosol (Figure S2), with
just a small proportion of the WT and D 2-3 NLRP3, and an evenCell 153, 348–361, April 11, 2013 ª2013 Elsevier Inc. 351
Figure 3. Effect of N-Terminal Deletions of NLRP3 on Mitochondrial Recruitment, ASC Speckle Formation, and IL-1b Secretion
(A and B) Quantification of ASC speckle formation in HEK293-ASC-YFP cells transiently transfected with low levels of WT or N-terminal deletions of NLRP3 (as in
Figures S2 and 2B), and either untreated (A) or treated with 15 mM nigericin (B) for 45 min prior to imaging.
(C) Quantification of colocalization of WT and N-terminal deletion mutants of NLRP3 with Mitotracker in HEK293-ASC-YFP cells transfected as above, and either
untreated or treated with 15 mM nigericin for 45 min prior to imaging.
(D) Minimum N-terminal sequence (2–7) necessary for NLRP3 mitochondrial association and ASC aggregation is indicated in red.
(E) ELISA for IL-1b in supernatants of PMA-differentiated (non-LPS-primed) THP-1 cells stably expressing NLRP3 WT or NLRP3 D 2-21, and stimulated with the
indicated NLRP3 activators. Expression of NLRP3 was induced for 12 hr with DOX (1 mg/ml), prior to differentiation with 100 nM PMA for 3 hr.
(F) Subcellular fractionation of HEK293T cells stably expressing either NLRP3 WT or NLRP3 D 2-21. NLRP3 expression was induced with 1 mg/ml DOX for 6 hr
prior to stimulation with nigericin for 45 min.
Data points in (A) and (B) represent the percentage of all transfected cells (pooled frommultiple fields) containing a fully developed, incompletely developed, or no
ASC speckle. At least 20 cells were evaluated for each construct. Data points in (C) represent independent fields (three to five cells per field). Data are repre-
sentative of three independent experiments. Error bars are mean ±SEM, and p values from an unpaired t test (two-tailed) are shown. ND; not detectable. See also
Figure S3.lesser proportion of the D 2-5 NLRP3 colocalized with mitochon-
dria in the higher expressing cells of the population (Figure S2).
These cells with low levels of NLRP3-mitochondria association
also showed ASC speckle formation (Figure S2, quantification
in Figure 3A), consistent with the notion that ASC aggregation
is an autocatalytic process that proceeds rapidly following a
speck nucleation event in the presence of NLRP3 (Cheng
et al., 2010). None of the other NLRP3 mutants (D 2-7, D 2-9, D
2-11, and D 2-21) showed this low level of mitochondrial associ-352 Cell 153, 348–361, April 11, 2013 ª2013 Elsevier Inc.ation and ASC aggregation in the absence of inflammasome
activating stimuli (Figure S2).
When stimulated with nigericin, markedly increased levels of
WT NLRP3 associated with mitochondria, but the N-terminal
deletions progressively lost their ability to associate with mito-
chondria and to form aggregates with ASC (Figure 2B, quantifi-
cation in Figures 3B and 3C). The D 2-7 deletion mutant,
exhibited remarkably diminished mitochondrial association and
ASC speckle formation, and the D 2-9 and D 2-11 deletion
mutants showed a complete loss of these properties (Figure 2B,
quantification in Figures 3B and 3C). Many cells expressing theD
2-5 mutant showed incomplete ASC aggregation, and all of the
cells expressing the D 2-7 mutant showed either incomplete or
no ASC speckle formation (Figure 3B). Incompletely developed
ASC speckles in these cells appeared as rudimentary, thread-
like structures (Figure 2B). Taken together, these results
indicated that residues 2-7 (KMASTR) constituted a minimum
N-terminal sequence necessary for both NLRP3 mitochondrial
association and maximal ASC aggregation (Figure 3D), and
that these processes were likely coupled. The disabling muta-
tions reduced mitochondrial association and speckle formation
but did not prevent NLRP3 self-association (Figure S3A),
suggesting that NLRP3 oligomerization and its recruitment to
mitochondria were separable functions and that some types of
NLRP3 self-association (as shown in Figure S3A for the D 2–9
and D 2–21 mutants) were not adequate to promote ASC
condensation.
Consistent with these localization data, endogenous NLRP3-
expressing THP-1 cells stably coexpressing the NLRP3 D 2-21
mutant under the control of a tetracycline-inducible promoter
lost their ability to secrete IL-1b in response to moderate levels
of known NLRP3-activators (Figure 3E), implying a dominant-
negative activity of this truncated protein. Because the D 2-21
mutant retained its ability to self-associate (Figure S3A), it is likely
that this mutant exerted its dominant-negative function by
scavenging the endogenous NLRP3 into defective oligomeric
complexes incapable of mitochondria-associated downstream
signaling. In agreement with these functional data, subcellular
fractionation of stably transduced HEK293T cells showed
markedly diminished levels of the D 2-21 NLRP3 mutant in the
mitochondrial fraction as compared to the WT NLRP3, following
induction with DOX and activation with nigericin (Figure 3F).
Identification of MAVS as Critical to NLRP3 Recruitment
to Mitochondria
We next asked whether an interacting mitochondrial partner
guides NLRP3 to this location. MAVS is a well-known mitochon-
drial protein that plays a crucial role in RIG-like receptor (RLR)
signaling pathways leading to type I IFN induction and NF-kB
activation (Kawai et al., 2005; Meylan et al., 2005; Seth et al.,
2005). MAVS plays a role in maintaining intestinal homeostasis
and MAVS/ mice do not upregulate IL-1b in an experimental
model of colitis (Li et al., 2011). Other studies suggest that NLRs
can engage in heterotypic protein-protein interactions (Bruey
et al., 2007; Eitas and Dangl, 2010; Hsu et al., 2008; Wagner
et al., 2009). We therefore examined whether MAVS might guide
NLRP3 to themitochondria by silencingMAVS in HEK293T cells.
Treatment of HEK293T cells with either of two different MAVS
siRNAs, but not control siRNAs, markedly reduced NLRP3 asso-
ciation with mitochondria following transient overexpression of
NLRP3 (Figures 4A and 4C andMovies S1 and S2). We observed
a similar dependence on MAVS for nigericin-induced NLRP3
association with mitochondria in a transient low-expression sys-
tem (Figures 4B and 4D). Biochemical studies showed increased
association between NLRP3 and MAVS in BMDMs upon treat-
ment with NLRP3-activating stimuli, but not upon exposure
to stimuli that activate other NLR family members, such asNLRC4 (flagellin), NLRP1/NOD2 (MDP), or AIM2 (transfected
DNA) (Figures 4E, S4E and S4F). Such NLRP3-MAVS asso-
ciation in macrophages did not correlate with cell death
(Figure S4G). Congruent results were obtained in immunoprecip-
itation and imaging studies in HEK293T cells (Figures S4A–S4C).
In accord with their impaired capacity to show mitochondrial
recruitment, N-terminal deletionmutants of NLRP3 also progres-
sively lost their ability to engageMAVS, based on coimmunopre-
cipitation analysis following cell exposure to nigericin as well as
direct binding studies utilizing in vitro translated NLRP3 and re-
combinant, soluble MAVS protein (Figures 4F and 4H and
S4D). A significant loss of association with MAVS was observed
progressively starting with the D 2-7 mutant (Figure 4F), implying
that this region of NLRP3 mediated its mitochondrial recruitment
activity by promoting direct NLRP3-MAVS interaction. Further-
more, adding the N terminus of NLRP3 to NLRP4, an NLR that
does not show mitochondrial localization, conferred on this
molecule the ability to associate with MAVS both in coimmuno-
precipitation experiments as well as in direct binding studies
using purified proteins (Figures 4G and 4H), showing that the
N terminus of NLRP3 was not only necessary but could be suffi-
cient for promoting direct association with MAVS.
Functional Role ofMAVS in NLRP3-Mediated Production
of Mature IL-1b
NLRP3 inflammasome assembly leads to caspase-1 activation
and processing of pro-IL-1b (Agostini et al., 2004). We thus
investigated a role for mitochondrial localization via MAVS in
NLRP3 inflammasome-mediated IL-1b generation. MAVS was
silenced in BMDMs from C57BL/6 mice prior to LPS priming
and stimulation with NLRP3, NLRC4, or AIM2 activators and
secreted IL-1bmeasured by ELISA. Treatment withMAVS siRNA
but not control siRNA reduced IL-1b secretion in response to
NLRP3 activators ATP, nigericin, and poly I:C, but not NLRC4
activator flagellin or AIM2 activator poly dA:dT, in a dose-
dependent manner, indicating that MAVS played an amplifying
role in NLRP3-dependent IL-1b secretion (Figures 5A–5F).
Congruent results were obtained in macrophages derived from
MAVS / mice by ELISA (Figures 6A–6F and S5C–S5F) and
immunoblotting (Figures 6G, S5A, and S5B). MAVS / macro-
phages showed normal priming of NLRP3, pro-IL-1b, and
procaspase-1 expression (Figures 6G, 6H, S5A, and S5B) and
displayed normal mitochondrial/MAMS (mitochondria-associ-
ated ER membranes) architecture (Figure S5G). However, these
cells showed reduced processing of caspase-1 and secretion
of mature IL-1b in response to subsaturating concentrations
of the NLRP3 activators ATP, nigericin, and poly I:C, though
not in response to NLRC4 or AIM2 activators (Figures 6A-6B,
6D-6F, 6G, S5C, and S5F), indicating that MAVS was required
for optimal NLRP3 inflammasome activation in myeloid cells
in vitro. There was a graded dependence on MAVS for cas-
pase-1 activation and IL-1b secretion depending upon the
dose and nature of the NLRP3 activator used, with poly I:C,
ATP, and nigericin showing maximal dependence on MAVS (in
the order poly I:C > ATP, nigericin; Figures 6A-6B, 6D, 6G, and
S5C). Caspase-1 and IL-1b processing in response to crystalline
substances such as alum, CPPD, and MSU, was, however,
largely independent of MAVS (Figures 6C, 6G, S5D, and S5E)Cell 153, 348–361, April 11, 2013 ª2013 Elsevier Inc. 353
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Figure 4. The Mitochondrial Adaptor MAVS Mediates NLRP3 Mitochondrial Localization
(A and C) Representative confocal immunofluorescence images (A) and quantification (C) of NLRP3 colocalized with Mitotracker in HEK293T cells treated with
control siRNA or MAVS siRNA prior to overexpression of NLRP3. siRNA transfected into cells appears as punctate spots shown in blue.
(B andD) Representative immunofluorescence images (B) and quantification (D, left) of HEK293T cells treatedwith control siRNA orMAVS siRNAprior to transient
low expression of NLRP3 and stimulation with 15 mM nigericin for 45 min. Immunoblot and corresponding densitometric quantification for efficiency of MAVS
knockdown are shown (D, right).
(E) Immunoblot showing NLRP3 association with MAVS in BMDMs upon treatment with activators of NLRP3, but not activators of NLRC4 or NOD2/NLRP1. In
some experiments, MAVS expression in lysates decreases upon stimulation with ATP for unknown reasons.
(legend continued on next page)
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andMAVS/mice were not reproducibly protected from crys-
tal-induced peritonitis (Figure S6D). Thus, although NLRP3 has
been shown to localize to the mitochondrial/MAM fraction
upon activation with crystalline activators such as MSU (Zhou
et al., 2011), other factors besides MAVS may mediate this
recruitment.
ASC is crucial for assembly of the NLRP3 inflammasome,
which yields a pyroptosome composed of ASC dimers and/or
oligomers that localizes to a detergent-insoluble fraction in the
cell (Fernandes-Alnemri et al., 2007). Because our imaging and
biochemical data in HEK293T cells suggested that NLRP3 mito-
chondrial localization and engagement of MAVS was indepen-
dent of ASC, we hypothesized that NLRP3 association with
MAVS might be upstream of its interaction with ASC. Indeed,
immunoblotting of the detergent-resistant fraction following acti-
vation of BMDMs with subsaturating concentrations of noncrys-
talline NLRP3 activators showed reduced ASC oligomerization
and localization to the detergent-resistant fraction in macro-
phages fromMAVS/mice compared toWTmice (Figure 6G).
These data suggested that MAVS was required for highly effi-
cient NLRP3 inflammasome activation resulting in maximal
ASC oligomerization/pyroptosome formation and subsequent
secretion of mature IL-1b (as depicted in Figure S7).
MAVS has a well-established role in induction of type 1 IFN in
response to viral infection. To determine if NLRP3 interaction
with MAVS led to type 1 IFN production, we analyzed human
monocytes following treatment with LPS-ATP, an exclusive acti-
vator of NLRP3 (Mariathasan et al., 2006), or infection with influ-
enza A strain HKX31, a known activator of the RIG-I-MAVS
pathway (Pichlmair et al., 2006). Treatment with LPS-ATP
induced IL-1b expression in monocytes, but minimal amounts
of IFN-b (over what would be expected from TRIF-dependent
LPS signaling). In contrast, infection with influenza A virus
HKX31 induced robust IFN-b expression, but negligible IL-1b
expression (Figure 5G), suggesting that these pathways might
be mutually exclusive under these conditions.
Importance of MAVS in an In Vivo Model of
Inflammasome-Mediated Immunopathology
Finally, we addressed the role of MAVS in inflammasome activa-
tion in vivo using a model of sterile inflammation, folic-acid-
induced acute tubular necrosis (ATN). Folic-acid-induced acute
kidney injury is characterized by necrosis of tubular cells, and
IL-1b and IL-18 are key promoters of the inflammatory response
to dying cells and subsequent tissue damage during ATN (Furui-
chi et al., 2006; Haq et al., 1998). NLRP3, ASC, and caspase-1-
deficient mice are protected from ATN, establishing a critical role
for the NLRP3 inflammasome in this model of sterile damage(F) Immunoblot showing progressive loss of MAVS association by N-terminal dele
lane(s) here and throughout. Cells were transiently transfected with low levels o
nigericin for 45 min prior to lysate preparation.
(G) Immunoblot showing MAVS association of NLRP4 with the added N terminus
with the indicated FLAG-tagged constructs (1 mg DNA/106 cells for 20 hr) prior to
(H) Immunoblot showing association of the indicated in vitro translated FLAG-tag
independent experiments. Nig, nigericin; flg, flagellin; MDP, muramyldipeptide.
periments. Data points on graphs in (C) and (D) represent individual fields with thre
and p values from an unpaired t test (two-tailed) are shown. See also Figure S4(Berry and Clatworthy, 2012; Faubel et al., 2004; Iyer et al.,
2009). Remarkably, MAVS-deficient mice, like ASC-deficient
mice, were protected from weight loss, renal dysfunction, and
renal pathology during ATN (Figures 7A–7C, and S6C). This pro-
tection was associated with a reduction in interstitial neutrophil
infiltration (Figures 7D and 7E) and IL-1b staining in the kidneys
of ASC andMAVS-deficient mice compared toWTmice (Figures
7F and 7G). Priming of NLRP3 and pro-IL-1b expression in the
kidney during ATN was normal in MAVS / and ASC /
mice (Figures S6A and S6B). Together, these data indicated
that MAVS, like ASC, was an important mediator of NLRP3 acti-
vation in vivo that was required for the sterile inflammatory
response in ATN.
DISCUSSION
The existing paradigm for NLR signaling is oligomerization with a
single adaptor protein that mediates information transfer to a
downstream effector. In the case of NLRP3, this involves interac-
tion of its PYD domain with a similar domain on ASC, which
through CARD domain interactions promotes conversion of pro-
caspase-1 to its enzymatically active form. The latter then
cleaves pro-IL-1b to generate the biologically functional cyto-
kine. Here, we provide evidence that this paradigm is incom-
plete. For optimal activity of the NLRP3 inflammasome, two
adapters are required. In addition to ASC, MAVS is needed
and acts to promote recruitment of NLRP3 to the mitochondria.
This recruitment, which depends on a short N-terminal sequence
in NLRP3, then promotes ASC ‘‘speckle’’ formation and the
downstream biochemical events associated with the activity of
the inflammasome (Figure S7). Overall, these findings suggest
a much more subtle and complex organization of microbial and
tissue damage sensing pathways than has been considered to
date. They also generalize the important role already ascribed
to intracellular relocalization in the operation of some cytosolic
sensors such as RIG-I, an event whose importance in NLRP3
inflammasome function has been controversial.
AlthoughMAVS is well recognized for promoting expression of
IFN-b downstream of RIG-I and MDA-5 detection of viral RNA
(Kawai et al., 2005), MAVS interaction with NLRP3 in response
to ATP contributed specifically to inflammasome-dependent
generation of IL-1b but not to induction of IFN-b (Figure 5G).
How might this occur? A recent study suggests that virus infec-
tion induces the formation of detergent-resistant, fibril-like, high
molecular weight aggregates of the MAVS protein and that these
aggregates are potent activators of IRF3 (Hou et al., 2011). It
remains to be examined whether NLRP3 activators induce
formation of such MAVS aggregates. However, given ourtion mutants of NLRP3 in HEK293T cells. ‘‘j’’ indicates removal of an irrelevant
f FLAG-tagged WT or N-terminal deletions of NLRP3, and treated with 15 mM
of NLRP3 (NLRP4 + 2–11) in HEK293T cells. Cells were transiently transfected
lysate preparation. Error bars are mean ± SEM.
ged NLR proteins with purified MAVS. Immunoblots are representative of two
Imaging data are representative of several images from two independent ex-
e to five cells per field (C) or 30–40 cells per field (D). Error bars aremean ±SEM,
and Movies S1 and S2.
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Figure 5. Silencing MAVS in BMDMs Reduces IL-1b Secretion in Response to NLRP3 Activators
(A–E) ELISA for IL-1b in supernatants of control or MAVS-silenced, LPS-primed BMDMs treated with the indicated concentrations of ATP and nigericin for 20min
(A and B), transfected poly I:C and poly dA:dT for 6 hr (C, E), or transfected flagellin for 2 hr (D).
(F) Immunoblot for efficiency of MAVS knockdown in BMDMs. MAVS-2 siRNA specifically silenced MAVS and was used for assessing IL-1b secretion shown
in (A)–(E).
(G) Quantitative RT-PCR for IFN-b (G, left) and pro-IL-1b (G, right) expression in human monocytes treated with NLRP3 activator LPS-ATP or RIG-I activator
influenza A strain HKX31 (multiplicity of infection = 1). mRNA expression was normalized to the housekeeping gene GAPDH. ELISA and RT-PCR data are
representative of two independent experiments. Error bars are mean ± SEM, and p values from an unpaired t test (two-tailed) are shown. *p < 0.05; **p < 0.01;
***p < 0.001; ns, not significant; ND, not detectable.observation of minimal induction of IFN-b by LPS-ATP (Fig-
ure 5G), one possibility is that formation of MAVS fibrils might
be an exclusive characteristic of RIG-I activation and that the
lack or inhibition of suchMAVS aggregation by NLRP3 activators
might permit this adaptor to promote ASC-dependent IL-1b
generation without activating the IRF3-interferon pathway.
These observations suggest a modified model for adaptor func-
tion, in which the biological outcome of signaling is determined356 Cell 153, 348–361, April 11, 2013 ª2013 Elsevier Inc.by the interplay of the adaptor (i.e., MAVS) with the upstream
sensor (i.e., RIG-I versus NLRP3) rather than by the properties
of the adaptor per se.
In the case of activators such as poly I:C that are believed to
have a dual role in both MDA-5-dependent type 1 IFN and
NLRP3-dependent IL-1b signaling (Rajan et al., 2010), the spec-
ificity of MAVS signaling could be dictated by the stimulus dose
or duration and cytosolic sensor expression. For instance, in
ED
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Figure 6. MAVS Is Required for Optimal Inflammasome Activation by Noncrystalline NLRP3 Activators In Vitro
(A–F) ELISA showing IL-1b secretion from WT and MAVS / macrophages. LPS-primed BMDMs were treated with the indicated concentrations
of ATP (A) or nigericin (B) for 20 min, alum crystals for 4 hr (C), transfected poly I:C for 6 hr (D), flagellin for 2 hr (E), or poly dA:dT for 6 hr (F). Error bars are
mean ± SEM.
(G) Immunoblots showing processing of IL-1b and caspase-1 and ASC oligomerization in WT and MAVS / macrophages. LPS-primed BMDMs were treated
with transfected poly I:C (2 mg/106 cells) for 6 hr, ATP (2.5 mM), and nigericin (7.5 mM) for 20min, alum crystals (200 mg/ml) for 6 hr or transfected flagellin (1 mg/106
cells) for 2 hr. Cell culture supernatants (Sup), cell lysates, and crosslinked pellets fromwhole-cell lysates were analyzed by immunoblotting as indicated. Different
doses of each NLRP3 activator were examined and representative blots at subsaturating doses are shown. ‘‘*’’ indicates nonspecific bands observed at higher
exposures.
(H) Immunoblot for NLRP3 following stimulation with LPS (1 mg/ml for 4 h). ‘‘*’’ indicates a nonspecific band. Data are representative of two independent
experiments. Error bars aremean ±SEM, and p values from an unpaired t test (two-tailed) are shown. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant; ND, not
detectable. Casp-1, caspase-1. See also Figures S5 and S7.
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unprimed macrophages, poly I:C induces robust MDA-5 and
MAVS-dependent type 1 IFN but not NLRP3-dependent IL-1b
secretion. However, following transcriptional induction of
NLRP3 and pro-IL-1b expression by NF-kB activators like LPS,
macrophages show NLRP3-dependent and MDA-5-indepen-
dent IL-1b secretion in response to poly I:C (Rajan et al., 2010).
Thus, the expression levels of the cytosolic sensorsmight dictate
which sensor (NLRP3 or MDA-5) engages MAVS and the subse-
quent signaling pathway that is triggered.
How do NLRP3 and MAVS interact? Our imaging, biochem-
ical, and direct binding data (Figures 2B, 3C, 4F, 4H, and S4D)
indicate that residues 2–7 at the N terminal of NLRP3 constitute
a minimum sequence that mediates NLRP3-MAVS interaction
and localization of activated NLRP3 to mitochondria. Indeed,
adding the N terminus (2-11) of NLRP3 to NLRP4, an NLR that
does not showmitochondrial localization, confers on it the ability
to associate with MAVS (Figures 4G and 4H) suggesting that the
N terminus of NLRP3 itself plays amajor role inmediating binding
to MAVS.
Given the large size of the inflammasome (Stutz et al., 2009),
and the capacity of NLR proteins to engage in homotypic and
heterotypic protein-protein interactions (Eitas and Dangl, 2010;
Wagner et al., 2009), it is possible that in addition to MAVS, there
might be other interacting partners, mitochondrial and/or non-
mitochondrial, which constitute the fully active NLRP3 inflamma-
some. In this regard, a recent report shows that a non-NLR
protein, GBP5, stimulates selective NLRP3 inflammasome
assembly (Shenoy et al., 2012). Moreover, our in vitro IL-1b
data reveal a varied dependence on MAVS for IL-1b secretion
depending upon the nature and dose of the NLRP3 activator,
with poly I:C, ATP, nigericin showing maximal dependence on
MAVS (poly I:C > ATP, nigericin), and crystalline substances
showing minimal dependence on MAVS for IL-1b secretion (Fig-
ures 6A–6D and S5C–S5E), suggesting that other factors be-
sides MAVS may mediate NLRP3 mitochondrial recruitment in
response to crystalline activators. Nonetheless, our results in
ATN, an in vivo model of sterile inflammation, suggest that
MAVS is as important as ASC in inducing neutrophil influx and
IL-1b production in response to tissue injury and necrosis (Fig-
ures 7D–7G). This indicates that at physiologically-relevant levels
of stimulation, there is a similar dependence on MAVS and ASC
for inflammasome activation.
Taken together, our findings reveal a previously undescribed
mechanism by which NLRP3 localization to the mitochondria
and inflammasome activation are regulated by the mitochondrial
adaptor protein MAVS, and identify an N-terminal sequence in
NLRP3 that supports its association with MAVS. These dataFigure 7. MAVS Is Essential for NLRP3 Inflammasome Function In Vivo
(A) Percentage weight loss of WT, MAVS /, and ASC / mice injected intrap
(B) Measurement of BUN (blood urea nitrogen) in sera of mice with ATN. (C) Repr
and ASC / mice at 36 hr after folic acid treatment.
(D and E) Representative confocal immunofluorescence images (D) and quantific
with ATN.
(F and G) Representative confocal immunofluorescence images (F) and quantifi
neutrophils (E) or IL-1b-positive cells (G) counted in five independent high power
Data points in (B, E, and G) represent individual mice. Error bars are mean ± SEM
three independent experiments. FA, folic acid. See also Figure S6.strengthen the view that mitochondria act as platforms facili-
tating innate immune responses and add to our understanding
of the molecular complexity of sensor and adaptor interactions
that promote effective host defense.
EXPERIMENTAL PROCEDURES
Detailed methods are described in Extended Experimental Procedures.
Mice
ASC / and MAVS +/ mice were kindly provided by Drs. V. Dixit, Genen-
tech, and Z. Chen, UT Southwestern, respectively. As heterozygous
MAVS +/ mice provided to us were 129/Sv x C57BL/6 hybrids, littermates
(males) from the crossing of heterozygous mice were used in individual exper-
iments. All procedures were approved by the NIAID Animal Care and Use
Committee (National Institutes of Health, Bethesda, MD).
Constructs and Stable Cell Lines
Generation of NLRP2, NLRP4, NOD1, and NLRP3 constructs, and lentivirally
transduced, DOX-inducible HEK293T and THP-1 cell lines expressing
NLRP3 are described in Extended Experimental Procedures. NLRP3 expres-
sion was induced with 1 mg/ml DOX for 12 hr. HEK293-ASC-YFP cells were
a kind gift of Dr. E. Latz, University of Bonn, Germany.
Transfections
HEK293T and HEK293-ASC-YFP cells were seeded on poly-L-lysine coated
2-chambered coverglass slides (Lab-tek, NUNC) and transfected with siRNA
oligos (100 nM) using Lipofectamine 2000 (Invitrogen) or plasmid DNA (1 mg
DNA/106 cells for 20 hr for overexpression or 0.1 mg DNA/106 cells for 8 hr
for transient low-expression) using Fugene 6 (Roche).
Immunofluorescence Staining and Confocal Microscopy
HEK293T cells were stained with Mitotracker Red (50 nM, 20 min, 37C,
Molecular Probes, Invitrogen), fix-permeabilized (BD cytofix-cytoperm), and
stained with primary antibodies (anti-NLRP3; Nalpy3a/Nalpy3b, Abcam
or anti-FLAG M2 antibody, Sigma), and suitable Alexa Fluor-conjugated
secondary antibodies (Molecular Probes, Invitrogen). Images were acquired
on a Leica SP5 Confocal Imaging System with a z step size of 0.5 mm to
1 mm and processed with Imaris software.
Cell Fractionation
Mitochondria were isolated from cells using a Mitochondria Isolation Kit
(Thermo Scientific) or as previously described (Wieckowski et al., 2009), lysed
in 2% SDS, and boiled with 23 reducing sample buffer for SDS-PAGE.
Inflammasome Activation
HEK293T cells were treated with 15 mM nigericin (Sigma) for 45 min prior to
imaging. Poly I:C was obtained from Amersham Biosciences. All other inflam-
masome stimulants were from InvivoGen. PMA-differentiated THP-1 cells and
LPS-primed BMDMs or peritoneal macrophages were treated with ATP (1.25,
2.5, or 5 mM) or nigericin (3.75, 7.5, or 15 mM) for 20 min; MSU or alum crystals
(200 mg/ml), poly I:C or poly dA:dT (indicated concentrations) for 6 hr; and
MDP (5 mg/ml), flagellin, or CPPD crystals (indicated concentrations) for 2 hr.During Acute Tubular Necrosis
eritoneally with 250 mg folic acid/kg body weight (n = 5 mice per group).
esentative hematoxylin-eosin stained images from kidneys of WT, MAVS /,
ation (E) of neutrophil influx at the corticomedullary junction in kidneys of mice
cation (G) of IL-1b-positive cells at the corticomedullary junction. The sum of
fields (2003) at the corticomedullary junction of each mouse kidney is shown.
, and p values from a two-tailed t test are shown. Results are representative of
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For detection of ASC oligomerization, pellets from whole-cell lysates were
crosslinked with disuccinimidyl suberate (DSS; Thermo Scientific) and boiled
with 13 sample buffer for immunoblot analysis.
Direct Binding Assays
MAVS was expressed in Drosophila S2 cells and purified from the medium by
Ni-NTA (QIAGEN) and size exclusion chromatography. FLAG-tagged WT and
mutant NLR proteins were prepared by in vitro translation using a reticulocyte
lysate system (TNT T7 Quick Coupled Transcription/Translation System,
Promega). The synthesized protein was captured on anti-FLAG coated beads,
and used in pull down assays with 5 mg of purified MAVS protein.
Immunoprecipitation and Immunoblot Analysis
Proteins in whole-cell lysates were immunoprecipitated with primary antibody
for 4 hr at 4C followed by anti-mouse or anti-rabbit Dynabeads (Invitrogen) for
1 hr at 4C, eluted with 13 SDS reducing sample buffer, electrophoresed on
4%–20% Novex Tris-Glycine Gels (Invitrogen), transferred to nitrocellulose
(Bio-Rad), probed with primary antibody followed by HRP-conjugated
secondary antibodies, and developed with SuperSignal Chemiluminescence
Substrate (Thermo Scientific). The following primary antibodies were used:
NLRP3 (Nalpy3a/Nalpy3b, Abcam; Cryo-2, Enzo life sciences), FLAG M2
(Sigma), HA (Sigma), humanCardif (Enzo life sciences), MAVS (rodent specific,
Cell Signaling Technology); IL-1b, caspase-1 and ASC (Santacruz Biotech)
and mouse IL-1b (R&D Systems).
ELISA
IL-1b in supernatants was measured using a IL-1b ELISA Kit (BD OptEIA; BD
Biosciences) following the manufacturer’s instructions.
Quantitative RT-PCR
Total RNA was extracted using RNAeasy Mini Kit (QIAGEN). Quantitative RT-
PCR for IL-1b and IFN-b was performed using FAM-labeled TaqMan MGB
probes (Applied Biosystems). mRNA levels were normalized to GAPDH
expression.
Folic-Acid-Induced Acute Tubular Necrosis
Folic acid (250 mg/kg, Sigma) or vehicle (150 mM sodium bicarbonate) was
administered intraperitoneally. Mice were weighed at 0, 12, 24, and 36 hr after
treatment, euthanized by CO2 asphyxiation at 36 hr, and blood samples and
kidneys were collected. Sera were evaluated for BUN (blood urea nitrogen).
One kidney was processed for hematoxylin and eosin (H&E) staining and the
other for immunofluorescence staining (see Extended Experimental Proce-
dures). Interstitial neutrophil infiltration and IL-1b-positive cells were quanti-
tated on 30 mm kidney sections stained with anti-Ly6G (1A8, BD Biosciences)
or anti-IL-1b (R&D Systems), together with a PECAM-1 antibody to identify
extravascular, interstitial neutrophils. Images were acquired on a 710 confocal
microscope (Zeiss) with a z step size of 2 mm. Raw images were processed and
analyzed with Imaris (Bitplane).
Statistical Analyses
Two-tailed, unpaired Student’s t tests were performed to analyze statistical
differences between groups (Prism, GraphPad). p values < 0.05 were con-
sidered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, one table, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2013.02.054.
ACKNOWLEDGMENTS
This work was supported by the Intramural Research Program, NIAID, NIH,
and a Wellcome Trust Intermediate Fellowship (WT081020) to M.R.C. We
are grateful to Drs. Daniel Kastner, Michael Lenardo, and Iain Fraser for critical
reading of the manuscript. We thank the Biological Imaging Section, NIAID,360 Cell 153, 348–361, April 11, 2013 ª2013 Elsevier Inc.NIH for excellent imaging support; Dr. Vishva Dixit and Dr. Zhijian Chen for
kindly providing mouse strains; Dr. Eicke Latz for generously providing HEK-
293-ASC-YFP cells; Dr. Iain Fraser for providing lentiviral constructs; and
Drs. Wolfgang Kastenmuller, Marlene Brandes, and Jae Jin Chae for helpful
discussions. The authors declare that they have no competing financial
interests.
Received: April 11, 2012
Revised: August 21, 2012
Accepted: February 22, 2013
Published: April 11, 2013
REFERENCES
Agostini, L., Martinon, F., Burns, K., McDermott, M.F., Hawkins, P.N., and
Tschopp, J. (2004). NALP3 forms an IL-1beta-processing inflammasome
with increased activity in Muckle-Wells autoinflammatory disorder. Immunity
20, 319–325.
Bae, J.Y., and Park, H.H. (2011). Crystal structure of NALP3 protein pyrin
domain (PYD) and its implications in inflammasome assembly. J. Biol.
Chem. 286, 39528–39536.
Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Nu´n˜ez, G., and
Hornung, V. (2011). Cutting edge: reactive oxygen species inhibitors block
priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 187,
613–617.
Berry, M., and Clatworthy, M.R. (2012). Immunotherapy for acute kidney injury.
Immunotherapy 4, 323–334.
Blasius, A.L., and Beutler, B. (2010). Intracellular toll-like receptors. Immunity
32, 305–315.
Bruey, J.M., Bruey-Sedano, N., Luciano, F., Zhai, D., Balpai, R., Xu, C., Kress,
C.L., Bailly-Maitre, B., Li, X., Osterman, A., et al. (2007). Bcl-2 and Bcl-XL regu-
late proinflammatory caspase-1 activation by interaction with NALP1. Cell 129,
45–56.
Cerretti, D.P., Kozlosky, C.J., Mosley, B., Nelson, N., Van Ness, K., Green-
street, T.A., March, C.J., Kronheim, S.R., Druck, T., Cannizzaro, L.A., et al.
(1992). Molecular cloning of the interleukin-1 beta converting enzyme. Science
256, 97–100.
Cheng, J., Waite, A.L., Tkaczyk, E.R., Ke, K., Richards, N., Hunt, A.J., and Gu-
mucio, D.L. (2010). Kinetic properties of ASC protein aggregation in epithelial
cells. J. Cell. Physiol. 222, 738–747.
Cruz, C.M., Rinna, A., Forman, H.J., Ventura, A.L., Persechini, P.M., and
Ojcius, D.M. (2007). ATP activates a reactive oxygen species-dependent
oxidative stress response and secretion of proinflammatory cytokines in
macrophages. J. Biol. Chem. 282, 2871–2879.
Davis, B.K., Wen, H., and Ting, J.P. (2011). The inflammasome NLRs in
immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29,
707–735.
Eitas, T.K., and Dangl, J.L. (2010). NB-LRR proteins: pairs, pieces, perception,
partners, and pathways. Curr. Opin. Plant Biol. 13, 472–477.
Faubel, S., Ljubanovic, D., Reznikov, L., Somerset, H., Dinarello, C.A., and
Edelstein, C.L. (2004). Caspase-1-deficient mice are protected against
cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int. 66,
2202–2213.
Fernandes-Alnemri, T., Wu, J., Yu, J.W., Datta, P., Miller, B., Jankowski, W.,
Rosenberg, S., Zhang, J., and Alnemri, E.S. (2007). The pyroptosome: a supra-
molecular assembly of ASC dimers mediating inflammatory cell death via cas-
pase-1 activation. Cell Death Differ. 14, 1590–1604.
Furuichi, K., Wada, T., Iwata, Y., Kokubo, S., Hara, A., Yamahana, J., Sugaya,
T., Iwakura, Y., Matsushima, K., Asano, M., et al. (2006). Interleukin-1-depen-
dent sequential chemokine expression and inflammatory cell infiltration in
ischemia-reperfusion injury. Crit. Care Med. 34, 2447–2455.
Gavel, Y., and von Heijne, G. (1990). Cleavage-site motifs in mitochondrial
targeting peptides. Protein Eng. 4, 33–37.
Goldbach-Mansky, R., and Kastner, D.L. (2009). Autoinflammation: the prom-
inent role of IL-1 in monogenic autoinflammatory diseases and implications for
common illnesses. J. Allergy Clin. Immunol. 124, 1141–1149, quiz 1150–1151.
Gross, O., Thomas, C.J., Guarda, G., and Tschopp, J. (2011). The inflamma-
some: an integrated view. Immunol. Rev. 243, 136–151.
Gu, B.J., Saunders, B.M., Jursik, C., and Wiley, J.S. (2010). The P2X7-non-
muscle myosin membrane complex regulates phagocytosis of nonopsonized
particles and bacteria by a pathway attenuated by extracellular ATP. Blood
115, 1621–1631.
Haq,M., Norman, J., Saba, S.R., Ramirez, G., and Rabb, H. (1998). Role of IL-1
in renal ischemic reperfusion injury. J. Am. Soc. Nephrol. 9, 614–619.
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L.,
Fitzgerald, K.A., and Latz, E. (2008). Silica crystals and aluminum salts activate
the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol.
9, 847–856.
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G.,
Caffrey, D.R., Latz, E., and Fitzgerald, K.A. (2009). AIM2 recognizes cytosolic
dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature
458, 514–518.
Hou, F., Sun, L., Zheng, H., Skaug, B., Jiang, Q.X., and Chen, Z.J. (2011).
MAVS forms functional prion-like aggregates to activate and propagate anti-
viral innate immune response. Cell 146, 448–461.
Hsu, L.C., Ali, S.R., McGillivray, S., Tseng, P.H., Mariathasan, S., Humke, E.W.,
Eckmann, L., Powell, J.J., Nizet, V., Dixit, V.M., and Karin, M. (2008). A NOD2-
NALP1 complex mediates caspase-1-dependent IL-1beta secretion in
response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl.
Acad. Sci. USA 105, 7803–7808.
Iyer, S.S., Pulskens, W.P., Sadler, J.J., Butter, L.M., Teske, G.J., Ulland, T.K.,
Eisenbarth, S.C., Florquin, S., Flavell, R.A., Leemans, J.C., and Sutterwala,
F.S. (2009). Necrotic cells trigger a sterile inflammatory response through
the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. USA 106, 20388–20393.
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J.,
Takeuchi, O., and Akira, S. (2005). IPS-1, an adaptor triggering RIG-I- and
Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981–988.
Li, X.D., Chiu, Y.H., Ismail, A.S., Behrendt, C.L., Wight-Carter, M., Hooper,
L.V., and Chen, Z.J. (2011). Mitochondrial antiviral signaling protein (MAVS)
monitors commensal bacteria and induces an immune response that prevents
experimental colitis. Proc. Natl. Acad. Sci. USA 108, 17390–17395.
Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O’Rourke, K., Roose-
Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M., and Dixit, V.M. (2006).
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature
440, 228–232.
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschl-
ager, R., and Tschopp, J. (2005). Cardif is an adaptor protein in the RIG-I anti-
viral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172.Nakahira, K., Haspel, J.A., Rathinam, V.A., Lee, S.J., Dolinay, T., Lam, H.C.,
Englert, J.A., Rabinovitch, M., Cernadas, M., Kim, H.P., et al. (2011). Auto-
phagy proteins regulate innate immune responses by inhibiting the release
of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol.
12, 222–230.
Nakai, K., and Kanehisa, M. (1992). A knowledge base for predicting protein
localization sites in eukaryotic cells. Genomics 14, 897–911.
Pichlmair, A., Schulz, O., Tan, C.P., Na¨slund, T.I., Liljestro¨m, P., Weber, F., and
Reis e Sousa, C. (2006). RIG-I-mediated antiviral responses to single-stranded
RNA bearing 50-phosphates. Science 314, 997–1001.
Rajan, J.V., Warren, S.E., Miao, E.A., and Aderem, A. (2010). Activation of the
NLRP3 inflammasome by intracellular poly I:C. FEBS Lett. 584, 4627–4632.
Rock, K.L., Latz, E., Ontiveros, F., and Kono, H. (2010). The sterile inflamma-
tory response. Annu. Rev. Immunol. 28, 321–342.
Seth, R.B., Sun, L., Ea, C.K., and Chen, Z.J. (2005). Identification and charac-
terization of MAVS, a mitochondrial antiviral signaling protein that activates
NF-kappaB and IRF 3. Cell 122, 669–682.
Shenoy, A.R., Wellington, D.A., Kumar, P., Kassa, H., Booth, C.J., Cresswell,
P., and MacMicking, J.D. (2012). GBP5 promotes NLRP3 inflammasome
assembly and immunity in mammals. Science 336, 481–485.
Shimada, K., Crother, T.R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S.,
Ramanujan, V.K., Wolf, A.J., Vergnes, L., Ojcius, D.M., et al. (2012). Oxidized
mitochondrial DNA activates the NLRP3 inflammasome during apoptosis.
Immunity 36, 401–414.
Shin, K.J., Wall, E.A., Zavzavadjian, J.R., Santat, L.A., Liu, J., Hwang, J.I., Re-
bres, R., Roach, T., Seaman, W., Simon, M.I., and Fraser, I.D. (2006). A single
lentiviral vector platform for microRNA-based conditional RNA interference
and coordinated transgene expression. Proc. Natl. Acad. Sci. USA 103,
13759–13764.
Stutz, A., Golenbock, D.T., and Latz, E. (2009). Inflammasomes: too big to
miss. J. Clin. Invest. 119, 3502–3511.
Wagner, R.N., Proell, M., Kufer, T.A., and Schwarzenbacher, R. (2009).
Evaluation of Nod-like receptor (NLR) effector domain interactions. PLoS
ONE 4, e4931.
Wieckowski, M.R., Giorgi, C., Lebiedzinska, M., Duszynski, J., and Pinton, P.
(2009). Isolation of mitochondria-associated membranes and mitochondria
from animal tissues and cells. Nat. Protoc. 4, 1582–1590.
Zhou, R., Tardivel, A., Thorens, B., Choi, I., and Tschopp, J. (2010). Thiore-
doxin-interacting protein links oxidative stress to inflammasome activation.
Nat. Immunol. 11, 136–140.
Zhou, R., Yazdi, A.S., Menu, P., and Tschopp, J. (2011). A role formitochondria
in NLRP3 inflammasome activation. Nature 469, 221–225.Cell 153, 348–361, April 11, 2013 ª2013 Elsevier Inc. 361
